Robert Silbergleit

Vericel Corporation is a biopharmaceutical company based in Ann Arbor, MI, specializing in advanced cell therapy products for the sports medicine and severe burn care markets. They manufacture and market two cell therapy products in the United States, and also hold an exclusive license for the North American commercial rights to NexoBrid, a biological orphan product approved for eschar removal of severe thermal burns. With a focus on innovative treatments and life-enhancing therapies, Vericel is dedicated to improving outcomes for patients in need of sports medicine and burn care. Their products, including MACI, Epicel, and NexoBrid, have been developed through extensive clinical development and scientific research, and have garnered positive attention and testimonials from patients and medical professionals alike.Generated from the website